-
German virologist: I don't think there will be a second outbreak in China now
Time of Update: 2020-11-27
BERLIN, June 17 (Xinhua) -- German virologist Jonas Schmidt-Chanasit said in German media on the 17th that China has responded well to the outbreak in Beijing, including rapid response, effective epidemic prevention efforts, large-scale testing and the rapid blockade of some areas.
-
The direction of development of Huiminbao
Time of Update: 2020-11-07
From the product itself, too low a premium price can not bring large-scale premium growth to insurance companies, but also subject to the lower scale of compensation, nor through the volume-for-price way to drive the impact on the back-end medical services market, through health management to promote the idea of stickiness is more difficult to achieve.
-
Dow Chemical expands the distribution of Palmer Holland
Time of Update: 2020-10-21
Dow Coatings will expand Palmer Holland's distribution to Canada.
, a manufacturer of water-based and solvent-based acrylic technology, will expand Palmer Holland's license to distribute DCM acrylic products in Canada starting March 1, 2020.
-
Novarca Piqray Treatment of PIK3CA Mutation HR-/HER2-Breast Cancer: Significantly Extended Lifetime
Time of Update: 2020-10-13
Piqray is the first and only treatment specifically approved for the treatment of patients with advanced breast cancer who carry the PIC3CA mutation in their tumors.
-
Kangfang BioPD-1/VEGF dual anti-AK112 starts clinically
Time of Update: 2020-10-01
Previously, the combination therapy of PD-1/PD-L1 antibodies and VEGF blockers has shown excellent results in a number of tumor indications, and has been approved in the United States tecentriq (Tershanqi, PD-L1 antibody) and Avastin (Avetin, VEGF blockers) for first-line treatment of hepatocellular and renal cell carcinoma.
-
Breakthrough drug for cholestasis! Phase III of the potent ileal bile acid transporter inhibitor odevixibat succeeded: reaching the European and American regulatory endpoint
Time of Update: 2020-09-26
results showed that the study reached two main endpoints: odevixibat significantly reduced bile acid response (SBA, p-0.003), significantly improved skin itching (p-0.004), and had a single-digit diarrhea rate compared to placebo.
-
NIH supports three companies in jointly developing "artificial pancreas" trials
Time of Update: 2020-09-14
trial, Tandem, Dexcom and TypeZero provided technology integration, representing a new level of development in artificial pancreas research and development.
" Although the closed-loop system enables the "inControl algorithm" to run on current smartphones, the designers hope to integrate Dexcom's G6 sensors into Tandem's t:slim X2 insulin pump and integrate the TypeZero algorithm directly into the insulin pump's touch screen.
-
Under the burst of innovation, Chinese pharmaceutical companies began the era of sea 2.0
Time of Update: 2020-09-10
future, Shi pharmaceutical group's internationalization path will gradually transition from product export to capital export, through international expansion of overseas advanced technology and resources to introduce domestic, combined with the application of the local market, and then seek the expansion of overseas markets.
-
Sea spiders: For the first time in nature, a blood delivery system using the intestines has been found
Time of Update: 2020-08-28
experiment used samples of 12 sea spiders from Antarctica and the United States and confirmed that arthropods living in the ocean use intestinal contractions to promote blood and oxygen flow.
-
Pfizer will produce Redsyve
Time of Update: 2020-08-21
under the agreement, Pfizer will provide contract manufacturing services at its McPherson, Kansas, plant to produce and supply Redcywe, Gilead.
meanwhile, Gilead aims to produce a sufficient number of Redsevetoby by the end of this year to treat more than 2 million PATIENTs with COVID-19, and the U.S. recently purchased almost all antiviral drugs as of September.
-
"First: Warby Medical completed hundreds of millions of dollars of B-plus round financing, to create a total stroke solution, based on the local to win overseas opportunities
Time of Update: 2020-08-11
Read: Hundreds of Millions of Financing Helps Stroke Solve PerfectLy. On August 11, , Shanghai Warby Medical Technology Co., Ltd. (Or: Warby Medical, Wallaby Medical) announced the completion of hundr
-
Fosun Pharma's new coronavirus mRNA vaccine was registered for clinical trial review
Time of Update: 2020-07-31
the vaccine is a biological product for prevention and is intended to be used mainly for the prevention of new coronaviruses in people aged 18 and over.
-
The first nuclear output inhibitor Xpovio 3 indications was accepted by the FDA in the United States
Time of Update: 2020-07-27
Original source: U.S Food and Drug Administration Accept SKaryopharm's Supplemental New Drug Application for XPOVIO ® (selinexor) as a Treatment for patients with Multiple Myeloma Mae At Os One First
-
U.S. biologist dies of infected cougar's plague bacteria
Time of Update: 2020-07-07
a wildlife scientist working in the Grand Canyon in Arizona, died after an autopsy on a sick cougar, tests showed he died of plague, according to U.S media reports , the 37-year-old wildlife
-
1 billion people died from smoke this century, warns WHO's latest report
Time of Update: 2020-07-04
Who's Director-General Margaret Chan and New York Mayor Michael Bloomberg jointly held a press conference Thursday to deliver a report The latest report from the World Health Organization warns that
